SCHEMBL6963247

SCHEMBL6963247

OCCCC1CCCN(c2ccncc2)C1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHKA P35790 1/20 0.46
LMNA P02545 1/20 0.40
NPC1 O15118 1/20 0.39
NR2F2 P24468 1/20 0.39
SYK P43405 2/20 0.38
DRD2 P14416 1/20 0.38
DRD3 P35462 1/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
KDM4E B2RXH2 2/20 0.37
POLB P06746 1/20 0.37
ADRB2 P07550 1/20 0.36
NCF1 P14598 1/20 0.36
PLD1 Q13393 1/20 0.36
MAPT P10636 1/20 0.36
ALDH1A1 P00352 2/20 0.35
CYP3A4 P08684 2/20 0.34
ITGB3 P05106 1/20 0.34
ITGA2B P08514 1/20 0.34
MAP4K4 O95819 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6958119 0.86 CHKA (0.46) CHKADRD2DRD3KDM4EPOLB
SCHEMBL7329597 0.82 CHKA (0.47) CHKADRD2DRD3ADRB2NCF1
SCHEMBL18082917 0.79 CHKA (0.52) CHKADRD2DRD3MEN1KMT2A
SCHEMBL803786 0.79 CHKA (0.52) CHKASYKDRD2DRD3ADRB2
SCHEMBL12424616 0.79 CHKA (0.52) CHKADRD2DRD3MEN1KMT2A
Hydrochloric Acid SCHEMBL785376 0.78 CHKA (0.50) CHKASYKDRD2DRD3ADRB2
SCHEMBL8100053 0.77 DPP4 (0.48) LMNAMEN1KMT2AKDM4EMAPT
SCHEMBL28179896 0.75 CHKA (0.47) CHKADRD2DRD3MEN1KMT2A
SCHEMBL786220 0.74 PPARA (0.43) CHKAMEN1KMT2AKDM4EMAPT
SCHEMBL15649907 0.74 MAPT (0.46) LMNANPC1SYKMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6620815-B1 Selective antagonists for human alpha 1A receptors; benign prostatic hyperplasia, impotency, cardiac arrhythmia treatment; anticholesterol agents; intraocular pressure reduction SYNAPTIC PHARMACEUTICAL CORPORATION 2003-09-16 US disclosed
EP-0988295-A4 HETEROCYCLIC SUBSTITUTED PIPERIDINES AND USES THEREOF SYNAPTIC PHARMA CORP (US) 2003-08-13 EP disclosed
US-6159990-A Oxazolidinones as α1A receptor antagonists SYNAPTIC PHARMACEUTICAL CORPORATION (US) 2000-12-12 US disclosed
EP-0988295-A1 HETEROCYCLIC SUBSTITUTED PIPERIDINES AND USES THEREOF SYNAPTIC PHARMACEUTICAL CORPORATION (US) 2000-03-29 EP disclosed
WO-1998057940-A1 HETEROCYCLIC SUBSTITUTED PIPERIDINES AND USES THEREOF SYNAPTIC PHARMACEUTICAL CORPORATION (US) 1998-12-23 WO disclosed